Assessing Differences in Timeliness of Emergency Department Pain Treatment for Adult Sickle Cell Pain and Renal Colic.

The American Society of Hematology (ASH) adopted a site-level quality measure (QM) quantifying differences in median time to first pain medication between adult sickle cell disease (SCD) vaso-occlusive episodes (VOE) and renal colic in emergency departments (EDs). Large-scale evaluation of this QM is lacking. We analyzed records from 103 U.S. adult EDs using 2019-2025 Epic Cosmos electronic health record data. Included sites had at least 100 SCD VOE and 100 renal colic encounters. The QM was calculated per site as median time to first pain medication for SCD VOE minus median time for renal colic, in minutes. Sites were categorized as SCD-Advantaged (<-10 min), Equivalent (±10 min), or SCD-Disadvantaged (>+10 min). Spearman correlations assessed relationships between QM scores and site-level SCD encounter volume, ED length of stay (LOS), and hospital admission rates. Across 103 adult EDs, 436,692 SCD VOE and 5,596,964 renal colic encounters were analyzed. QM scores ranged from -145 to +91 minutes (median: +4). Most sites (56.3%) demonstrated equivalent first-analgesia timeliness; 15.5% provided faster analgesia for SCD VOE, while 28.2% showed delays for SCD VOE (>+10 minutes, median gap: +19 min). QM scores were not associated with SCD encounter volume (p = 0.42), ED LOS (p = 0.94), or hospital admission rate (p = 0.34). We found no major differences in acute pain-care timeliness for SCD versus renal colic across most sites; however, several EDs demonstrated opportunities for improvement. These findings establish the first national baseline for the ASH QM.

Authors

Institutions

Publication Details

Journal
Blood Advances
Published
2026-11-17
DOI
https://doi.org/10.1182/bloodadvances.2026021103
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Assessing Differences in Timeliness of Emergency Department Pain Treatment for Adult Sickle Cell Pain and Renal Colic.

Ibrahim Gwarzo, David C. Brousseau, Harish Chandra Dega
5 links
Blood Advances
Hemoglobinopathies and Related Disorders
article

Assessing Differences in Timeliness of Emergency Department Pain Treatment for Adult Sickle Cell Pain and Renal Colic.

Ibrahim Gwarzo, David C. Brousseau, Harish Chandra Dega
article en

Abstract

The American Society of Hematology (ASH) adopted a site-level quality measure (QM) quantifying differences in median time to first pain medication between adult sickle cell disease (SCD) vaso-occlusive episodes (VOE) and renal colic in emergency departments (EDs). Large-scale evaluation of this QM is lacking. We analyzed records from 103 U.S. adult EDs using 2019-2025 Epic Cosmos electronic health record data. Included sites had at least 100 SCD VOE and 100 renal colic encounters. The QM was calculated per site as median time to first pain medication for SCD VOE minus median time for renal colic, in minutes. Sites were categorized as SCD-Advantaged (<-10 min), Equivalent (±10 min), or SCD-Disadvantaged (>+10 min). Spearman correlations assessed relationships between QM scores and site-level SCD encounter volume, ED length of stay (LOS), and hospital admission rates. Across 103 adult EDs, 436,692 SCD VOE and 5,596,964 renal colic encounters were analyzed. QM scores ranged from -145 to +91 minutes (median: +4). Most sites (56.3%) demonstrated equivalent first-analgesia timeliness; 15.5% provided faster analgesia for SCD VOE, while 28.2% showed delays for SCD VOE (>+10 minutes, median gap: +19 min). QM scores were not associated with SCD encounter volume (p = 0.42), ED LOS (p = 0.94), or hospital admission rate (p = 0.34). We found no major differences in acute pain-care timeliness for SCD versus renal colic across most sites; however, several EDs demonstrated opportunities for improvement. These findings establish the first national baseline for the ASH QM.

Blood Advances
DuPont (United States) (US), Nemours Children's Health System (US)
Good health and well-being
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon